---
title: Protheragen vs Tigermed
slug_a: obesityscientific
slug_b: tigermedgrp
site: cro
review_signal_gate: closed
canonical_path: /compare/obesityscientific/tigermedgrp
---

# Protheragen vs Tigermed

Side-by-side profile data from each company listing on this directory.

## Protheragen

- Profile: [/companies/obesityscientific](/companies/obesityscientific)

Protheragen — Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

Services: 27. Modalities: 5. Indications: 1. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (27).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Cell Therapy
- Gene Therapy
- Peptide

### Indications

- Metabolic

### Phases

- Preclinical (General)
- Phase I
- Discovery
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## Tigermed

- Profile: [/companies/tigermedgrp](/companies/tigermedgrp)

Tigermed — Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.

Services: 37. Modalities: 9. Indications: 10. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (37).

### Services

- High-Throughput Screening
- Medicinal Chemistry
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Translational Research
- Microbiology Services
- Virology Services
- Immunology & Inflammation Services
- Oncology Specialty Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
- Device & Combination Product Services

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- Cell Therapy
- Gene Therapy
- Peptide
- Vaccine
- Radiopharmaceutical

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Ophthalmology
- Gastroenterology

### Phases

- Preclinical (General)
- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)